Format

Send to

Choose Destination
Int J Womens Health. 2012;4:455-69. doi: 10.2147/IJWH.S24783. Epub 2012 Sep 3.

Clinical role of bisphosphonate therapy.

Author information

1
Osteoporosis Screening Unit, Guy's Hospital, London, UK ; Department of Chemical Pathology, St Thomas' Hospital, London, UK.

Abstract

Bisphosphonates (BPs) are synthetic analogues of pyrophosphate. They inhibit bone resorption and are therefore widely used in disorders where there are increases or disruptions in bone resorption. This includes postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, Paget's disease of bone, and malignancy-related bone loss. To best understand the clinical application of BPs, an understanding of their pharmacokinetics and pharmacodynamics is important. This review describes the structure, pharmacology and mode of action of BPs, focusing on their role in clinical practice. Controversies and side effects surrounding their use will also be discussed.

KEYWORDS:

Paget’s disease of bone; bone resorption; glucocorticoid-induced osteoporosis; malignancy-related bone loss; postmenopausal osteoporosis; pyrophosphate

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center